Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: United States, AR

Clinical Trial Details

Overview

Research Study Summary

Are you a diabetic with cardiovascular disease that has recently been hospitalized for a coronary event?

Purpose

The purpose of this clinical research study is to evaluate the effectiveness of an investigational drug in preventing cardiovascular, heart and blood vessel events by lowering the blood sugar in subjects with Type II Diabetes.

Patient Inclusion Criteria:

  • Experienced a coronary event at least 5 days and no more than 12 weeks ago
  • History of type 2 diabetes

Patient Exclusion Criteria:

  • Under 30 years of age
  • Type 1 diabetes mellitus
  • Pregnancy
  • Other GLP-1 receptor agonists or DPP-IV inhibitors (e.g., exenatide, liraglutide, vildagliptin, sitagliptin)

To Learn more
Gender

Both Male and Female

Age

Up to 30 Years

Overall Status

Recruiting

Facility Type

N/A

Contact

Paul Koros, RN, Site Manager
NEA Baptist Clinic - Clinical Research Center
416 E. Washington, Suite C
Jonesboro, AR 72401
Phone: 870-934-1006
Fax: 870-934-1008

View Map

Research Center Information: NEA Baptist Clinic - Clinical Research Center

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 166703

Date Last Changed: July 23, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.